Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Turcotte

Showing results (141-150 of 163) with videos related to

Pageof 17
Sort By:
JAMA Pediatrics|October 29, 2019
Association of Breast Cancer Risk After Childhood Cancer With Radiation Dose to the Breast and Anthracycline Use: A Report From the Childhood Cancer Survivor StudyLene H Veiga, Rochelle E Curtis, Lindsay M Morton, et al.
Journal of the National Cancer Institute|March 9, 2024
Impact of risk-based therapy on late morbidity and mortality in neuroblastoma survivors: a report from the Childhood Cancer Survivor StudyDanielle Novetsky Friedman, Pamela J Goodman, Wendy M Leisenring, et al.
The Journal of Investigative Dermatology|March 27, 2019
Genome-Wide Association Study in Irradiated Childhood Cancer Survivors Identifies HTR2A for Subsequent Basal Cell CarcinomaYadav Sapkota, Lucie M Turcotte, Matthew J Ehrhardt, et al.
BMJ Open|November 7, 2022
Cohort profile: Risk and risk factors for female breast cancer after treatment for childhood and adolescent cancer: an internationally pooled cohortYuehan Wang, Leontien C M Kremer, Flora E van Leeuwen, et al.
Nature Medicine|September 11, 2023
Subsequent female breast cancer risk associated with anthracycline chemotherapy for childhood cancerYuehan Wang, Cécile M Ronckers, Flora E van Leeuwen, et al.
JCO Precision Oncology|September 14, 2020
Subsequent Neoplasm Risk Associated With Rare Variants in DNA Damage Response and Clinical Radiation Sensitivity Syndrome Genes in the Childhood Cancer Survivor StudyLindsay M Morton, Danielle M Karyadi, Stephen W Hartley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2026
Reply to: Methodologic Considerations for Subsequent Colorectal Cancer in Survivors of Childhood CancerConstance A Owens, Ethan B Ludmir, Qi Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2021
Development and Validation of a Breast Cancer Risk Prediction Model for Childhood Cancer Survivors Treated With Chest Radiation: A Report From the Childhood Cancer Survivor Study and the Dutch Hodgkin Late Effects and LATER CohortsChaya S Moskowitz, Cécile M Ronckers, Joanne F Chou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2025
Colorectal-Specific Radiation Dose and Chemotherapy Risk for Subsequent Colorectal Malignancies in Childhood Cancer Survivors: A Childhood Cancer Survivor Study (CCSS) ReportConstance A Owens, Ethan B Ludmir, Qi Liu, et al.
Cancer Discovery|April 19, 2026
Therapy-related mutational signatures in subsequent neoplasms among survivors of childhood cancerSamuel W Brady, Michael A Arnold, Mingjuan Wang, et al.
Pageof 17

Showing results (141-150 of 163) with videos related to

Sort By:
Pageof 17
JAMA Pediatrics|October 29, 2019
Association of Breast Cancer Risk After Childhood Cancer With Radiation Dose to the Breast and Anthracycline Use: A Report From the Childhood Cancer Survivor StudyLene H Veiga, Rochelle E Curtis, Lindsay M Morton, et al.
Journal of the National Cancer Institute|March 9, 2024
Impact of risk-based therapy on late morbidity and mortality in neuroblastoma survivors: a report from the Childhood Cancer Survivor StudyDanielle Novetsky Friedman, Pamela J Goodman, Wendy M Leisenring, et al.
The Journal of Investigative Dermatology|March 27, 2019
Genome-Wide Association Study in Irradiated Childhood Cancer Survivors Identifies HTR2A for Subsequent Basal Cell CarcinomaYadav Sapkota, Lucie M Turcotte, Matthew J Ehrhardt, et al.
BMJ Open|November 7, 2022
Cohort profile: Risk and risk factors for female breast cancer after treatment for childhood and adolescent cancer: an internationally pooled cohortYuehan Wang, Leontien C M Kremer, Flora E van Leeuwen, et al.
Nature Medicine|September 11, 2023
Subsequent female breast cancer risk associated with anthracycline chemotherapy for childhood cancerYuehan Wang, Cécile M Ronckers, Flora E van Leeuwen, et al.
JCO Precision Oncology|September 14, 2020
Subsequent Neoplasm Risk Associated With Rare Variants in DNA Damage Response and Clinical Radiation Sensitivity Syndrome Genes in the Childhood Cancer Survivor StudyLindsay M Morton, Danielle M Karyadi, Stephen W Hartley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2026
Reply to: Methodologic Considerations for Subsequent Colorectal Cancer in Survivors of Childhood CancerConstance A Owens, Ethan B Ludmir, Qi Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2021
Development and Validation of a Breast Cancer Risk Prediction Model for Childhood Cancer Survivors Treated With Chest Radiation: A Report From the Childhood Cancer Survivor Study and the Dutch Hodgkin Late Effects and LATER CohortsChaya S Moskowitz, Cécile M Ronckers, Joanne F Chou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2025
Colorectal-Specific Radiation Dose and Chemotherapy Risk for Subsequent Colorectal Malignancies in Childhood Cancer Survivors: A Childhood Cancer Survivor Study (CCSS) ReportConstance A Owens, Ethan B Ludmir, Qi Liu, et al.
Cancer Discovery|April 19, 2026
Therapy-related mutational signatures in subsequent neoplasms among survivors of childhood cancerSamuel W Brady, Michael A Arnold, Mingjuan Wang, et al.
Pageof 17